US2008181945A2PendingUtilityA2
Method for the treatment of acne
Assignee: MEDICIS PHARMACEUTICAL CORPPriority: Jun 24, 2005Filed: Jul 12, 2007Published: Jul 31, 2008
Est. expiryJun 24, 2025(expired)· nominal 20-yr term from priority
A61P 31/02A61K 31/65A61P 17/10
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
Claims
exact text as granted — not AI-modified1 . A method of preparing an oral dosage form for administration once a day that provides a continuous release of an oral minocycline, comprising:
combining an antibiotically effective dose of said oral minocycline and a pharmaceutically suitable delivery vehicle having a fast dissolving carrier and a slow dissolving carrier to form a combination, said fast dissolving carrier and said slow dissolving carrier having a weight ratio of about 0.3 to about 0.5 of fast dissolving carrier to slow dissolving carrier; wherein said oral dosage form upon administration releases said oral minocycline to provide a patient with about 0.5 mg/kg/day to about 1.5 mg/kg/day of said oral minocycline.
2 . The method of claim 1 , wherein said oral minocycline is minocycline as hydrochloride.
3 . The method of claim 1 , wherein the weight ratio of fast dissolving carrier to slow dissolving carrier is about 0.35 to about 0.45.
4 . The method of claim 1 , wherein the weight ratio of fast dissolving carrier to slow dissolving carrier is about 0.36 to about 0.40.
5 . The method of claim 1 , wherein said fast dissolving carrier comprises lactose monohydrate.
6 . The method of claim 1 , wherein said slow dissolving carrier comprises HPMC.
7 . The method of claim 1 , wherein:
said fast dissolving carrier comprises lactose monohydrate; and said slow dissolving carrier comprises HPMC.
8 . The method of claim 1 , wherein said slow dissolving carrier is present at about 23.5 to about 27.0% by weight of the oral dosage form.
9 . The method of claim 1 , wherein said slow dissolving carrier is present at:
23.5% by weight of said oral dosage form when said oral dosage form comprises 135 mg of said oral minocycline; or 27.0% by weight of said oral dosage form when said oral dosage form comprises 45 mg of said oral minocycline.
10 . The method of claim 1 , wherein compressing said combination forms said oral dosage form into a tablet.
11 . (canceled)
12 . The method of claim 1 , further comprising an intragranular fast dissolving carrier.
13 . The method of claim 12 , wherein said slow dissolving carrier encapsulates at least a portion of said intragranular fast dissolving carrier.
14 . The method of claim 1 , further comprising adding a coating to said combination to form said oral dosage form.
15 . The method of claim 1 , further comprising compressing said combination.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.